Tirzepatide targets GLP-1 and GIP receptors to lower blood sugar, reduce hunger cues, and slow digestion so you feel full faster
Promotional price valid on web orders only
Gallstone Attacks and Bile Duct Blockage GLP-1 therapies can affect the gallbladder in several ways, leading to gallstones and even bile duct blockages
Eating without distractions such as phones or television helps you tune into satiety signals more accurately
Glucose All subjects were normoglycemic at fasting baseline, with levels between 4.4 and 5.6 mmol/L (median 5.25 mmol/L), and glucose levels dropped below baseline after the meal for all subjects during both SAL and EXE infusions
In rare cases, GLP-1 receptor agonists can lead to more serious side effects, such as pancreatitis (inflammation of the pancreas), thyroid tumours, or kidney problems